首页> 美国卫生研究院文献>BMC Bioinformatics >Predicting population coverage of T-cell epitope-based diagnostics and vaccines
【2h】

Predicting population coverage of T-cell epitope-based diagnostics and vaccines

机译:预测基于T细胞表位的诊断剂和疫苗的人群覆盖率

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundT cells recognize a complex between a specific major histocompatibility complex (MHC) molecule and a particular pathogen-derived epitope. A given epitope will elicit a response only in individuals that express an MHC molecule capable of binding that particular epitope. MHC molecules are extremely polymorphic and over a thousand different human MHC (HLA) alleles are known. A disproportionate amount of MHC polymorphism occurs in positions constituting the peptide-binding region, and as a result, MHC molecules exhibit a widely varying binding specificity. In the design of peptide-based vaccines and diagnostics, the issue of population coverage in relation to MHC polymorphism is further complicated by the fact that different HLA types are expressed at dramatically different frequencies in different ethnicities. Thus, without careful consideration, a vaccine or diagnostic with ethnically biased population coverage could result.
机译:BackgroundT细胞识别特定的主要组织相容性复合物(MHC)分子和特定的病原体衍生的表位之间的复合物。给定的表位仅在表达能够结合特定表位的MHC分子的个体中引起应答。 MHC分子极为多态,已知超过一千种人类MHC(HLA)等位基因。 MHC多态性的数量不成比例地出现在构成肽结合区的位置,结果,MHC分子表现出很大的结合特异性。在基于肽的疫苗和诊断试剂的设计中,由于不同种族的HLA类型以不同的频率表达,这一事实使与MHC多态性有关的人群覆盖问题更加复杂。因此,如果不仔细考虑,可能会导致疫苗或诊断带有种族偏见的人群覆盖率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号